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The GATA transcription factors GLN3 and GAT1 acti-
vate nitrogen-regulated genes in Saccharomyces cerevi-
siae. NPR1 is a protein kinase that controls post-Golgi
sorting of amino acid permeases. In the presence of a
good nitrogen source, TOR (target of rapamycin) main-
tains GLN3 and NPR1 phosphorylated and inactive by
inhibiting the type 2A-related phosphatase SIT4. We
identified NPR1 as a regulator of GLN3. Specifically,
loss of NPR1 causes nuclear translocation and activa-
tion of GLN3, but not GAT1, in nitrogen-rich conditions.
NPR1-mediated inhibition of GLN3 is independent of
the phosphatase SIT4. We also demonstrate that the
E3/E4 ubiquitin-protein ligase proteins RSP5 and
BUL1/2 are required for GLN3 activation under poor
nitrogen conditions. Thus, NPR1 and BUL1/2 antagonis-
tically control GLN3-dependent transcription, suggest-
ing a role for regulated ubiquitination in the control of
nutrient-responsive transcription.
In yeast, the quality of the available nitrogen source controls
the expression of genes encoding proteins required for the
uptake and assimilation of nitrogenous compounds. This regu-
latory process is mediated by four GATA transcription factors,
the activators GLN3 and GAT1/NIL1 and the repressors
DAL80 and DEH1/NIL2/GZF3. GLN3 is the major activator of
nitrogen-regulated genes (for recent reviews, see Refs. 1 and 2).
URE2 is a GLN3-binding protein that retains GLN3 in the
cytoplasm to prevent its nuclear translocation and activation
during growth under good nitrogen conditions.
The two homologous kinases TOR11 and TOR2 are central
controllers of cell growth, and their inactivation with rapamy-
cin causes physiological changes characteristic of nutrient-
starved cells (3, 4). A TOR signaling pathway regulates the
expression of nitrogen-regulated genes by inhibiting GLN3 and
GAT1 (5). In the presence of a preferred nitrogen source such as
NH4
 or glutamine, TOR promotes complex formation between
GLN3 and URE2 by maintaining GLN3 in the phosphorylated
state necessary for URE2 binding (5). Upon nitrogen limitation
or rapamycin treatment, the TOR-controlled phosphatase SIT4
causes GLN3 dephosphorylation, and GLN3 dissociates from
URE2 and translocates into the nucleus to activate target
genes (5).
NPR1 encodes a Ser/Thr kinase that controls the post-Golgi
sorting and degradation of amino acid permeases. NPR1 in-
versely regulates GAP1, the general amino acid permease, and
TAT2, a tryptophan permease (2). In cells grown in poor nitro-
gen sources, NPR1 is dephosphorylated by the TOR-modulated
SIT4 phosphatase to become active (6). In turn, active NPR1
allows GAP1 to reach the plasma membrane and causes the
rapid degradation of TAT2. In cells shifted to a good nitrogen
source medium, plasma membrane GAP1 is internalized and
pre-existing permease is no longer delivered to the plasma
membrane, whereas TAT2 is stabilized at the plasma mem-
brane (7–9). GAP1 down-regulation occurs via its ubiquitina-
tion by the E3 ubiquitin protein ligase RSP5 in conjunction
with the RSP5-binding proteins BUL1 and BUL2 (8, 10, 11).
Here, we identify NPR1 as a negative regulator of GLN3-de-
pendent transcription. Deletion of NPR1 causes nuclear local-
ization and activation of GLN3 during growth on a good nitro-
gen source. Activation of GLN3 in npr1 mutant cells requires
the presence of functional RSP5 and BUL1/2 proteins, and
BUL1/2 proteins are necessary for the activation of GLN3
under nitrogen starvation conditions. Thus, a ubiquitin-de-
pendent signaling pathway appears to control GLN3-depend-
ent transcription.
MATERIALS AND METHODS
Strains, Media, and Reagents—The complete genotypes of the
yeast strains used in this study are listed in Table I. Standard
techniques and media were used (22). The SD medium contained
NH4
 as nitrogen source and the amino acids required for auxotro-
phies. All cultures were incubated at 30 °C. Rapamycin was used at a
final concentration of 200 ng/ml.
Plasmids—pJC10 (YCplac111-based), used to screen for regulators of
GLN3, was obtained by PCR amplification of the MEP2 promoter (from
nucleotide 827 to 1) and the HIS3 gene (from nucleotide 1 to 913).
pJC20 expressing functional single HA-tagged NPR1 under control of
own promoter was obtained by cloning a 2.2-kb fragment containing the
NPR1 promoter and a 2.6-kb fragment from pAS103 (6) containing
HA-NPR1 into YCplac33. pJC21 expressing kinase-dead single HA-
tagged NPR1 was constructed by replacing the 2.6-kb fragment from
pJC20 by a 2.6-kb fragment from pAS104 containing HA-NPR1 with
the mutation K467R. YCpMEP2-lacZ was described previously (12).
Screen for Regulators of GLN3—TB50 cells containing pJC10 were
transformed with DNA from an mTn-3HA/GFP/URA3 library, grown
in SD medium for 2 h, and plated on SD-Ura-Leu-His medium supple-
mented with 5 mM 3-amino-1,2,4-triazole. Colonies that formed after 4
days incubation at 30 °C were tested for growth on plates of SD medium
without His containing 10 mM 3-amino-1,2,4-triazole. The genomic site
of transposon insertion was identified following the “vectorette PCR”
method (23).
Microarray Analysis—Total RNA was prepared by hot phenol extrac-
tion (24) from duplicate samples grown in SD medium to mid-logarith-
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mic phase. For microarray analysis, RNA was reverse transcribed, and
cDNA was prepared using Superscript II reverse transcriptase (Invitro-
gen). The cDNA was used as template for the production of biotin-
labeled cRNA using a RNA transcript labeling kit (Enzo). Finally, the
labeled cRNA was purified using RNeasy spin columns (Qiagen), frag-
mented by incubation with potassium/magnesium acetate and hybrid-
ized to Affymetrix S98 Yeast GeneChips, as recommended by the man-
ufacturer. Raw expression signals for each transcript were computed
using the algorithm implemented in MAS 5.0 (Affymetrix). The robust
multichip average method, implemented as a part of the BioConductor
(bioconductor.org) package affy, was employed for data normalization,
background correction, and summarization (25).
Indirect Immunofluorescence—GLN3-Myc and GAT1-HA were visu-
alized by indirect immunofluorescence on whole fixed cells as described
(26). DNA was stained with 4,6-diamidino-2-phenylindole (DAPI;
Sigma) at a concentration of 1 g/ml. Cells were visualized with a Zeiss
Axiophot microscope (100 objective).
Western Blot—GLN3-Myc was detected by Western blot as described
previously (5).
Determination of Intracellular Amino Acid Pools—The intracellular
levels of amino acids were determined as described (26).
RESULTS
Identification of the NPR1 as a Negative Regulator of Nitro-
gen-controlled Genes—To find new regulators of GATA tran-
scription factors, we performed a transposon insertion screen to
identify mutations in genes whose products are required to
repress GLN3 and/or GAT1 under rich nitrogen conditions. A
strain expressing the HIS3 gene from the GLN3-/GAT1-de-
pendent promoter of the NH4
 permease MEP2 (PMEP2-HIS3)
(12) cannot survive in NH4
 medium lacking histidine because
GLN3 and GAT1 are inactive, whereas e.g. his3 ure2 cells can
grow under the same conditions because of the constitutive
activation of at least GLN3 (Fig. 1A). We identified a mutation
in NPR1 that allows growth of his3 PMEP2-HIS3 cells on NH4

medium lacking histidine (Fig. 1A), suggesting that NPR1 is
normally required to repress GLN3 and/or GAT1 during
growth in a good nitrogen source.
To confirm that npr1 causes expression of MEP2, we as-
sessed the expression of a second reporter, PMEP2-lacZ, in wild
type, npr1, and ure2 cells. Expression from PMEP2-lacZ was
12 times higher in npr1 cells and 25 times higher in ure2
cells compared with that from the wild-type strain (Fig. 1B).
NPR1 is a protein kinase, and we transformed npr1 cells with
plasmids carrying NPR1 (pJC20) or npr1kin that encodes
kinase-dead NPR1 (pJC21). Only the kinase-dead NPR1 failed
to reduce PMEP2-lacZ expression, suggesting that the ki-
nase activity of NPR1 is required for the repression of MEP2
expression (Fig. 1B).
NPR1 Represses GLN3 but Not GAT1—To determine
whether the effect of NPR1 on transcription is mediated by
GLN3 and/or the GLN3-like GATA factor GAT1, we measured
-galactosidase activity in npr1, npr1 gln3, and npr1 gat1
mutants containing PMEP2-lacZ. Deletion of GLN3 abolished
PMEP2-lacZ expression in an npr1 mutant, whereas loss of
GAT1 had no significant effect (Fig. 2A). To extend these ob-
servations, we assessed GLN3 and GAT1 localization in wild-
type and npr1 cells. GLN3 was localized in the cytoplasm in
wild-type cells but was partially nuclear in npr1 cells (Fig. 2B).
This nuclear accumulation of GLN3 in npr1 cells was less
pronounced than in ure2 cells where GLN3 is strongly nuclear
(Fig. 2B), which is consistent with the levels of PMEP2-lacZ
expression in npr1 and ure2 strains (Fig. 1B). In contrast,
GAT1 was cytoplasmic in both wild-type and npr1 cells (Fig.
2B). In addition, in a ure2 strain there was only a weak accu-
TABLE I
Strains used in this study
Strain Genotype
JK9-3da MATa leu2–3,112 ura3–52 trp1 his4 rme1 HMLa
TB50a MATa leu2–3,112 ura3–52 trp1 his3 rme1 HMLa
23344c MATa ura3
27038a MATa ura3 npi1
30788a MATa ura3 npr1::kanMX2
30788d MATa ura3 npi1 npr1::kanMX2
JC19-1a TB50a npr1::HIS3MX
JC28-1b TB50a npr1::HIS3MX sit4::kanMX
JC31-3b TB50a npr1::HIS3MX gln3::kanMX
JC32-2a TB50a npr1::HIS3MX gat1::HIS3MX
JC35-1c TB50a ure2::kanMX
JC40-1a JK9–3da ure2::URA3 GAT1-HA-kanMX
JC48-1c TB50a npr1::kanMX
JC52-2a JK9–3da npr1::URA3 GLN3-myc13-kanMX
JC53-1d JK9–3da npr1::URA3 GAT1-HA-kanMX
JC54-5a TB50a ure2::kanMX sit4::kanMX
JC59-12a TB50a npr1::kanMX bul1::kanMX bul2::HIS3MX
JC60-4b TB50a bul1::kanMX bul2::HIS3MX
JC62-1a TB50a lst4::kanMX
JC63-8b TB50a GLN3-myc13-kanMX bul1::kanMX
bul2::HIS3MX
TB102-1a JK9–3da gat1::kanMX
TB103-1d TB50a gln3::HIS3MX
TB106-2a JK9–3da GAT1-HA-kanMX
TB123 JK9–3da GLN3-myc13-kanMX
TB138-1a JK9–3da ure2::URA3 GLN3-myc13-kanMX
TS64-1a JK9–3da sit4::kanMX
FIG. 1. NPR1 inhibits expression of a GLN3/GAT1-regulated
gene, MEP2. A, loss of NPR1 or URE2 function allows growth on NH4

medium lacking histidine in his3-deficient cells expressing MEP2-
driven HIS3. Wild-type (wt) (TB50), npr1 (JC48-1c) and ure2 (JC35-1c)
mutant cells harboring pJC10 were streaked on NH4
 medium lacking
leucine (SD Leu) or NH4
 medium lacking histidine (SD His) sup-
plemented with 10 mM 3-amino-1,2,4-triazole (3-AT). B, wild-type
(TB50), npr1 (JC19-1a), and ure2 (JC35-1c) mutant cells transformed
with YCpMEP2-lacZ were grown in SD medium to an A600 of 0.5. Cells
were then collected and processed for -galactosidase assay. npr1 mu-
tant cells were also transformed with pJC20 or pJC21 and processed for
-galactosidase assay. 100% of -galactosidase activity corresponds to
1149 Miller units.
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mulation of GAT1 in the nucleus (Fig. 2B), indicating that
URE2 regulates the cellular localization of GLN3 but has little
effect on GAT1. The above results indicate that NPR1 inhibits
GLN3 but not GAT1.
NPR1-mediated Inhibition of GLN3 Is Independent of LST4,
LST8, and the Intracellular Level of Amino Acids—NPR1 is a
protein kinase required for post-Golgi sorting of the general
amino acid permease GAP1 and the three known ammonia
permeases, MEP1/2/3, to the plasma membrane. It is therefore
possible that the loss of NPR1 may indirectly activate GLN3 by
altering amino acid and/or ammonia metabolism. However,
under the conditions in which we measured GLN3 activity,
GAP1 activity is extremely low regardless of expression levels
(13), and even if GAP1 is expressed significantly higher in npr1
cells as compared with wild type, GAP1 would still not be
expected to reach the plasma membrane (14).
To confirm this hypothesis, we considered other mutations
known to affect Gap1p sorting to the plasma membrane. lst4
and lst8 mutations, like npr1, prevent GAP1 arrival at the
plasma membrane under poor nitrogen conditions (15). We
asked whether an lst4 mutation, like an npr1 mutation, af-
fects GLN3 activity. Loss of LST4 failed to induce PMEP2-lacZ
expression (Fig. 3A). We demonstrated previously that cells
depleted of LST8 express GLN3-regulated genes at levels
similar to those of wild-type cells (16). Thus, although loss of
NPR1, LST4, or LST8 can affect GAP1 sorting, loss of only
NPR1 results in the activation of GLN3 under our experi-
mental conditions.
Compared with wild type, cells lacking all three ammonia
permeases exhibit a severe growth defect in media containing 1
mM NH4
 but grow normally on media containing 40 mM or
more NH4
. Thus, at 76 mM NH4
, the conditions our cells
experience, there are additional mechanisms to take up NH4

ions, so loss of MEP1/2/3 activity caused by the loss of NPR1
does not appear to affect the availability of ammonia for intra-
cellular metabolism. Furthermore, the npr1 strain exhibited
the same very mild slow growth defect at 1 mM as at 40 mM
NH4
 as assessed by colony size following serial dilution spot-
ting onto solid minimal media (data not shown). Thus, it is
unlikely that GLN3 activation is occurring primarily because of
reduced intracellular levels of NH4
.
It is possible that GLN3 is activated in npr1 cells because of
reduced intracellular amino acid concentrations resulting from
altered trafficking of permeases other than GAP1 or MEP1/2/3.
To rule out this possibility, we measured the concentration of
amino acids in wild type and npr1 strains grown in minimal
media (SD) containing only those amino acids required to cor-
rect for auxotrophies (His, Leu, and Trp). In the npr1 strain the
total amount of all measured amino acids remained similar
(Fig. 3B). Importantly, glutamine and glutamate levels were
only slightly altered in the npr1 strain as compared with wild
type, with glutamine levels slightly increasing and glutamate
levels slightly decreasing. We demonstrated previously that
GLN3 is activated by a decrease in glutamine (26). Thus, these
minor alterations in amino acid concentrations in an npr1
strain do not correlate with the greatly increased activity of
GLN3 in the same strain. Thus, the activation of GLN3 in npr1
cells does not appear to be due to an indirect effect of altered
amino acid concentrations that could occur by inappropriate
permease sorting.
NPR1-mediated Inhibition of GLN3 Is Independent of
SIT4—NPR1 is regulated in part by SIT4 phosphatase, which,
in turn, is regulated by TOR (17). The SIT4 protein phospha-
tase is also required for GLN3 activation following rapamycin
treatment, so we asked whether GLN3 activation in npr1 cells
also requires SIT4. The expression of PMEP2-lacZ in wild type
and sit4 strains was similarly low, and in npr1 and npr1 sit4
strains it was similarly high (Fig. 4A). This epistasis of npr1 to
sit4 suggests that NPR1 acts downstream of SIT4 in GLN3
repression. We also examined the phosphorylation state of
GLN3 in npr1 mutant cells. In npr1 cells GLN3 appears to be
phosphorylated as in wild-type cells, because rapamycin treat-
ment increases the mobility of GLN3 (Fig. 4B). The simplest
model compatible with these observation is that SIT4 regulates
GLN3 via NPR1, but NPR1 does not regulate GLN3 directly.
FIG. 2. NPR1 inhibits GLN3 but not GAT1. A, -galactosidase
activity in wild-type (wt) (TB50), npr1 (JC19-1a), gln3 (TB103-1d), gat1
(TB102-1a), npr1 gln3 (JC31-3b), and npr1 gat1 (JC32-2a) mutant cells
transformed with YCpMEP2-lacZ. All strains have similar growth rates
under the test conditions. 100% of -galactosidase activity corresponds
to 1087 Miller units. B, localization of GLN3-Myc (GLN3) and
GAT1-HA (GAT1) in wild-type (TB123 for GLN3 and TB106-2a for
GAT1), npr1 (JC52-2a for GLN3 and JC53-1d for GAT1), and ure2
(TB138-1a for GLN3 and JC40-1a for GAT1) mutant cells. All strains
were grown in SD medium at 30 °C to an A600 of 0.5. Cells and DNA
were visualized by Nomarski optics and 4,6-diamidino-2-phenylindole.
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It has been shown that the GLN3 nuclear importin SRP1 is
capable of binding only non-phosphorylated GLN3 in vitro, and
it has thus been proposed that dephosphorylation of GLN3 is
necessary for its nuclear translocation (18). However, in npr1
and ure2 cells GLN3 is phosphorylated and predominantly
nuclear, suggesting that the phosphorylation state of GLN3
does not directly regulate its translocation. An alternative
model consistent with these data is that GLN3 phosphorylation
controls its binding to URE2 (5).
Activation of GLN3 in npr1 Mutants Requires RSP5, BUL1,
and BUL2—NPR1 and the E3/E4 ubiquitin ligase complex
composed of RSP5, BUL1, and BUL2 control nitrogen-regu-
lated trafficking of GAP1 antagonistically (2). To investigate
whether RSP5 and BUL1/2 are required for GLN3 activation in
npr1 cells, we analyzed the expression of PMEP2-lacZ in wild
type or npr1 cells lacking RSP5 or BUL1/2. The absence of
RSP5 or BUL1/2 alone had no effect on lacZ activity. However,
the mutation of either RSP5 or BUL1/2 in npr1 mutant cells
completely suppressed MEP2 expression (Fig. 5A), indicating
that RSP5 and BUL1/2 are necessary for GLN3 activation in
npr1 cells. The finding that rsp5 and bul1/2 mutations are
epistatic to npr1 suggests that the ubiquitin ligase is down-
stream of the NPR1 kinase.
BUL1/2 Proteins Are Required for Activation of GLN3 upon a
Shift to Proline but Not upon Rapamycin Treatment—To better
define the antagonistic role of NPR1 and BUL1/2 in the control
of nitrogen-regulated genes, we assessed the relative changes
in mRNA levels of a subset of genes known to be regulated by
GLN3 in wild type, npr1, and bul1 bul2 cells grown under three
different nitrogen related conditions (see “Materials and
FIG. 5. Derepression of MEP2 in an npr1 mutant requires
RSP5, BUL1, and BUL2. Wild-type (wt) (TB50), npr1 (JC19-1a), bul1
bul2 (JC60-4b), and npr1 bul1 bul2 (JC59-12a) and wild-type (23344c),
npr1 (30788a), rsp5 (27038a), and npr1 rsp5 (30788d) strains in the
1278b genetic background were transformed with the YCpMEP2-lacZ.
All strains were grown in SD medium to an A600 of 0.5 and processed for
-galactosidase assay. 100% of -galactosidase activity corresponds to
1319 Miller units.
FIG. 3. Derepression of GLN3 is not due to altered amino acid pools caused by permease sorting defects. A, wild-type (wt) (TB50),
npr1 (JC19-1a), and lst4 (JC62-1a) strains in the JK9 genetic background were transformed with the YCpMEP2-lacZ, grown in SD medium with
His, Leu, Trp, and Ura to an A600 of 0.5, and processed for -galactosidase assay. 100% of -galactosidase activity corresponds to 1319 Miller units.
B, intracellular pools of amino acids in wild-type (TB50) and npr1 (JC19-1a) mutant cells grown in SD medium with His, Leu, Trp, and Ura to an
A600 of 0.5. Units are nanomoles of amino acids per A600 of yeast cells; values represent mean  S.D. of three determinations.
FIG. 4. NPR1-mediated inhibition of GLN3 is independent of
SIT4. A, -galactosidase activity in wild-type (wt) (TB50), npr1 (JC19-
1a), ure2 (JC35-1c), sit4 (TS64-1a), npr1 sit4 (JC28-1b), and ure2 sit4
(JC54-5a) mutant cells transformed with YCpMEP2-lacZ. Cells were
grown and processed as described in the Fig. 1B legend. 100% of
-galactosidase activity corresponds to 1179 Miller units. B, GLN3 is
phosphorylated in an npr1 mutant and hyperphosphorylated in a ure2
mutant. Wild-type (TB123), npr1 (JC52-2a), and ure2 (TB138-1a) mu-
tant cells were grown in SD medium to an A600 of 0.5 and treated with
either rapamycin or a drug vehicle for 30 min. GLN3 was detected
by immunoblotting.
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Methods”). Table II shows the relative changes of a subset of
nitrogen source-regulated genes in the three strains mentioned
above grown under the following conditions: (i) grown in a good
nitrogen source (NH4
); (ii) shifted from a good to a poor nit-
rogen source for 30 min (NH4
 to proline); and (iii) grown in a
good nitrogen source (NH4
) and treated with rapamycin for 30
min. As expected, the known GLN3-regulated genes in Table II
were derepressed in npr1 cells and unaltered or down-regul-
ated in bul1 bul2 as compared with wild-type, confirming the
antagonistic effect of npr1 and bul1 bul2 mutations. These
genes are also all derepressed upon shifting a wild type strain
to either proline or treating with rapamycin, events known to
increase GLN3-dependent transcription. Although we are
preparing a comprehensive genome-wide study of NPR1/BUL-
1/2-dependent gene expression,2 the subset of known GLN3
regulated genes that we have selected here clearly demonstr-
ates that NPR1 and BUL1/2 are antagonistically involved in
the control of GLN3 activity.
Proline failed to induce a significant transcriptional response
in bul1 bul2 cells (Table II), indicating that these ubiquitina-
tion factors are an integral part of the proline-sensing tran-
scription pathway. Curiously, rapamycin-induced transcrip-
tion of the genes in Table II in bul1 bul2 cells was similar to
that of wild type cells. To further investigate the differential
effect of proline and rapamycin, we examined the nuclear
translocation of GLN3 in wild-type and bul1 bul2 cells follow-
ing a shift to proline or rapamycin treatment. Consistent with
the above findings, both conditions induced nuclear localization
of GLN3 in wild type cells, but only rapamycin induced nuclear
localization of GLN3 in a bul1 bul2 mutant (Fig. 6). Thus, the
BUL1/2 proteins are required for nuclear localization of GLN3
upon a shift to proline but not upon rapamycin treatment,
supporting previous suggestions that proline is sensed differ-
ently and suggesting that the RSP5/BUL1/2 complex is specif-
ically involved in GLN3 regulation. Indeed, growth in proline
specifically activates the rapamycin-sensitive proline utiliza-
tion pathway, including the transcription factor PUT3 (19).
2 S. Helliwell, C. Wiederkehr, P. Demougin, M. Primig, and M. Hall,
manuscript in preparation.
FIG. 6. BUL1/2 proteins are re-
quired for nuclear localization of
GLN3 upon nitrogen starvation. Lo-
calization of GLN3-Myc in wild-type (wt)
(TB123) and bul1 bul2 (JC63-8b) mutant
cells grown in SD medium (NH4
) to an
A600 of 0.5 and shifted from these condi-
tions to a proline-containing medium
(Pro) for 30 min or treated with rapamy-
cin (rap) for 30 min. Cells were processed
as described in the Fig. 2A legend. DAPI,
4,6-diamidino-2-phenylindole.
FIG. 7. A model for the control of GLN3 activation. Solid gray
indicates those parts of the pathway that are active in a good nitrogen
source. See “Discussion” for more details.
TABLE II
Fold-induction of known nitrogen source-regulated genes in the strains and conditions noted
Values given are relative to expression levels in wild type (WT) cells grown in ammonium media and represent the mean of duplicate microarray
experiments. References (Refs.) for genes known to be a nitrogen source or GLN3-regulated (Nit./GLN3) are indicated.
Gene
Ammonium Proline (30 min) Rapamycin (30 min)
Nit./GLN3 (Refs.)
WT npr1 bul1 bul2 WT npr1 bul1 bul2 WT npr1 bul1 bul2
MEP2 1 4.6 0.4 5 4 0.5 6.3 4.3 5.6 12
DUR3 1 2.7 0.2 3.5 2.9 0.2 4.6 2.2 4.2 27
DAL80 1 10.1 1.2 6.1 26.1 1.1 40.6 32.9 37.9 28
DAL5 1 4.9 0.6 8.7 13.9 0.8 21.2 16.4 18 29
DAL7 1 1.8 0.3 3.2 1.8 0.4 2.8 1.2 2.4 29
GAP1 1 2.1 0.3 2.2 2.5 0.8 2.5 2.2 2.4 30
CAN1 1 1.7 0.7 2 2 0.8 1.8 1.7 2.6 30
DAL1 1 2.8 0.7 10.4 3.5 0.9 6.1 2.2 5.2 30
PUT4 1 1.3 0.3 1.6 2.1 0.5 2.2 2.3 1.6 30
DAL3 1 4.6 0.5 10.1 3.4 1.1 8 3.1 10.1 28
OPT2 1 3.4 0.7 5.6 8.4 1 9.5 10.5 8.1 31
CPS1 1 2 0.7 2.5 3.6 0.9 6.6 4.9 3.4 32
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DISCUSSION
We have shown previously that NPR1 is controlled by TOR
and the phosphatase SIT4 (17). Here, we show that the kinase
NPR1 and the E3/E4 ubiquitin ligase complex composed of
RSP5 and BUL1/2 have antagonistic roles in the nuclear im-
port and activation of the transcription factor GLN3. NPR1
inhibits and the ubiquitin ligase promotes GLN3 activity. Fur-
thermore, our finding that rsp5 (npi1) and bul1 bul2 mutations
are epistatic to an npr1 mutation suggests that the ubiquitin
ligase acts downstream of NPR1 in activating GLN3 (Fig. 7).
Thus, this may constitute a novel ubiquitin-dependent signal-
ing pathway controlling transcription. The membrane-associ-
ated transcription factors SPT23 and MGA1 are ubiquitinated
and activated in an RSP5-dependent manner (20). However, we
have been unable to detect GLN3 ubiquitination. Alternative
possibilities are that the GLN3 inhibitor URE2 or the GLN3
nuclear import machinery is regulated by ubiquitination.
In yeast cells grown in a good nitrogen source, GLN3 is
repressed by the nitrogen sensing TOR-SIT4 pathway (5). As
shown in Fig. 7, we suggest that NPR1 acts downstream of
SIT4 to repress GLN3 directly or indirectly. It has been pro-
posed that, under nitrogen rich conditions, NPR1 is phospho-
rylated and thus inactive toward amino acid permeases (6, 14).
The results presented here suggest that phosphorylated NPR1
is active with regard to GLN3 repression. Thus phosphoryla-
tion of NPR1 may regulate substrate specificity rather than
activity per se.
Several lines of evidence argue against the idea that npr1
mutation affects GLN3 activity solely indirectly, via altered
nitrogen source uptake, due to incorrect nitrogen source per-
mease sorting (21). First, a reduction in the cytoplasmic nitro-
gen source would be expected to activate both GLN3 and GAT1,
and the npr1 mutation causes constitutive nuclear localization
and activation of only GLN3 and not GAT1 (Fig. 2). Second,
under the conditions we are using for these experiments (76 mM
NH4
), even a strain lacking all three known ammonia per-
meases (mep1/2/3) can grow perfectly well (12), and our npr1
strain forms colonies of similar size on solid media containing
concentrations of NH4
 ranging from 1 to 80 mM, suggesting
that the availability of intracellular ammonia is not signifi-
cantly compromised. Third, the other permeases that NPR1 is
known to positively regulate are GAP1 and PUT4, and neither
of these permeases are expected to be active under our exper-
imental conditions regardless of their transcription; also, mu-
tations in genes that also regulate GAP1, LST4 and LST8 do
not cause GLN3 activation. Fourth, total and specific intracel-
lular amino acid concentrations do not alter significantly in a
npr1 strain as compared with the wild type (Fig. 3B). Thus,
although we cannot absolutely rule out that there is some effect
due to altered permease sorting, it seems likely that a more
direct pathway is involved.
Importantly rapamycin but not proline induces GLN3 acti-
vation in a bul1 bul2 mutant. Thus, rapamycin-mediated inhi-
bition of the TOR pathway can bypass the requirement for
RSP5/BUL1/2 in GLN3 activation. Loss of the GLN3 cytoplas-
mic binding protein URE2 also circumvents the requirement
for the ubiquitination machinery in GLN3 activation (data not
shown). Thus, there appears to be two TOR-dependent inputs
into GLN3 activation, depending on the nature of the signal.
The first would be an RSP5- and BUL1/2-dependent input in
response to proline. The second would be an RSP5- and BUL1/
2-independent input in response to some other nitrogen source.
The qualitative and/or quantitative differences between the
signals transduced by these two inputs remains to be eluci-
dated, but either can be sufficient for GLN3 activation. Because
a ure2 mutation has a similar effect in a bul1 bul2 mutant as
rapamycin treatment, the RSP5-BUL1/2-independent input
may be the one controlling the binding of GLN3 to URE2.
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